Literature DB >> 11796370

Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations.

María-Cristina Negri1, María-Isabel Morosini, María-Rosario Baquero, Rosa del Campo, Jesús Blázquez, Fernando Baquero.   

Abstract

A mixed culture of an hypermutable hexA Streptococcus pneumoniae mutant strain and its hexA(+) isogenic ancestor was challenged with low cefotaxime concentrations. Despite identical original cefotaxime MICs, the hexA mutant population was significantly selected at very low concentrations, and all of the tested selected variants harbored the Thr550-->Ala mutation in pbp2x. Since cefotaxime selects hypermutators, the risk of secondary acquisition of antibiotic resistance is increased; as expected, the cefotaxime-resistant mutants had a mutation frequency 10 times higher in response to to ciprofloxacin. The present study presents a model (not necessarily reflecting the clinical setting) illustrating the risk of selection of mutators in the evolution of multiple resistance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796370      PMCID: PMC127056          DOI: 10.1128/AAC.46.2.528-530.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

Review 1.  Evolution of evolvability.

Authors:  M Radman; I Matic; F Taddei
Journal:  Ann N Y Acad Sci       Date:  1999-05-18       Impact factor: 5.691

2.  Hyperrecombination in Streptococcus pneumoniae depends on an atypical mutY homologue.

Authors:  M M Samrakandi; F Pasta
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

3.  High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

Authors:  A Oliver; R Cantón; P Campo; F Baquero; J Blázquez
Journal:  Science       Date:  2000-05-19       Impact factor: 47.728

4.  Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997).

Authors:  J J Granizo; L Aguilar; J Casal; C García-Rey; R Dal-Ré; F Baquero
Journal:  J Antimicrob Chemother       Date:  2000-11       Impact factor: 5.790

5.  Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America.

Authors:  A Tait-Kamradt; T Davies; P C Appelbaum; F Depardieu; P Courvalin; J Petitpas; L Wondrack; A Walker; M R Jacobs; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

6.  Development of competence in Streptococcus pneumonaie: pheromone autoinduction and control of quorum sensing by the oligopeptide permease.

Authors:  G Alloing; B Martin; C Granadel; J P Claverys
Journal:  Mol Microbiol       Date:  1998-07       Impact factor: 3.501

7.  Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics.

Authors:  T Grebe; R Hakenbeck
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

8.  Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins.

Authors:  T J Coffey; M Daniels; L K McDougal; C G Dowson; F C Tenover; B G Spratt
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

9.  Homeologous recombination and mismatch repair during transformation in Streptococcus pneumoniae: saturation of the Hex mismatch repair system.

Authors:  O Humbert; M Prudhomme; R Hakenbeck; C G Dowson; J P Claverys
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

Review 10.  Emerging mechanisms of fluoroquinolone resistance.

Authors:  D C Hooper
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

View more
  8 in total

1.  Identifying mutator phenotypes among fluoroquinolone-resistant strains of Streptococcus pneumoniae using fluctuation analysis.

Authors:  Carolyn V Gould; Paul D Sniegowski; Mikhail Shchepetov; Joshua P Metlay; Jeffrey N Weiser
Journal:  Antimicrob Agents Chemother       Date:  2007-07-30       Impact factor: 5.191

2.  Adaptive tuning of mutation rates allows fast response to lethal stress in Escherichia coli.

Authors:  Toon Swings; Bram Van den Bergh; Sander Wuyts; Eline Oeyen; Karin Voordeckers; Kevin J Verstrepen; Maarten Fauvart; Natalie Verstraeten; Jan Michiels
Journal:  Elife       Date:  2017-05-02       Impact factor: 8.140

3.  An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.

Authors:  Ilka Zerfass; Regine Hakenbeck; Dalia Denapaite
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

4.  Deciphering Evolutionary Mechanisms Between Mutualistic and Pathogenic Symbioses.

Authors:  M K Nishiguchi; A M Hirsch; R Devinney; G Vedantam; M A Riley; L M Mansky
Journal:  Vie Milieu       Date:  2008       Impact factor: 0.236

5.  High frequency plasmid recombination mediated by 28 bp direct repeats.

Authors:  Sofia C Ribeiro; Pedro H Oliveira; Duarte M F Prazeres; Gabriel A Monteiro
Journal:  Mol Biotechnol       Date:  2008-07-08       Impact factor: 2.695

6.  Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation.

Authors:  María-Isabel Morosini; María-Rosario Baquero; J M Sánchez-Romero; María-Cristina Negri; Juan-Carlos Galán; Rosa del Campo; J C Pérez-Díaz; Fernando Baquero
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

7.  Promoter Identification and Transcription Analysis of Penicillin-Binding Protein Genes in Streptococcus pneumoniae R6.

Authors:  Katharina Peters; Julia Pipo; Inga Schweizer; Regine Hakenbeck; Dalia Denapaite
Journal:  Microb Drug Resist       Date:  2016-07-13       Impact factor: 3.431

8.  Novel Insights into Selection for Antibiotic Resistance in Complex Microbial Communities.

Authors:  Aimee K Murray; Lihong Zhang; Xiaole Yin; Tong Zhang; Angus Buckling; Jason Snape; William H Gaze
Journal:  MBio       Date:  2018-07-24       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.